4th International Consensus Conference: Primary Systemic Treatment in the Management of Operable Breast Cancer: Toward the Rapid Assessment of Therapy EfficacyBOTTINI, Alberto; BERRUTI, Alfredo; GENERALI, Daniele et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, issn 1052-6773, 101 p.Conference Proceedings

Intermediate Endpoints of Primary Systemic Therapy in Breast Cancer PatientsBERRUTI, Alfredo; GENERALI, Daniele; BERTAGLIA, Valentina et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 142-146, issn 1052-6773, 5 p.Conference Paper

Mechanisms of Resistance to HER2 Target TherapyTORTORA, Giampaolo.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 95-98, issn 1052-6773, 4 p.Conference Paper

Neoadjuvant Chemotherapy and Targeted Therapies: a Promising StrategyMETZGER-FILHO, Otto; DE AZAMBUJA, Evandro.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 116-119, issn 1052-6773, 4 p.Conference Paper

Strategies to Translate Preclinical Information to Breast Cancer Patient BenefitDAIDONE, Maria Grazia; ZAFFARONI, Nadia; CAPPELLETTI, Vera et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 55-59, issn 1052-6773, 5 p.Conference Paper

kConFab: A Familial Breast Cancer Consortium Facilitating Research and Translational OncologyTHORNE, Heather; MITCHELL, Gillian; FOX, Stephen et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 79-81, issn 1052-6773, 3 p.Conference Paper

Bridging the Gap Between Translational Research and Clinical ApplicationMILLER, William R; LARIONOV, Alexey A.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 134-137, issn 1052-6773, 4 p.Conference Paper

The HER2 World: Better Treatment Selection for Better OutcomeTAGLIABUE, Elda; CAMPIGLIO, Manuela; PUPA, Serenella M et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 82-85, issn 1052-6773, 4 p.Conference Paper

Biomarkers Predicting Clinical Benefit: Fact or Fiction?GUARNERI, Valentina; BARBIERI, Elena; CONTE, Pierfranco et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 63-66, issn 1052-6773, 4 p.Conference Paper

Gene Profiling Assay and Application: The Predictive Role in Primary TherapyFUMAGALLI, Debora; DESMEDT, Christine; IGNATIADIS, Michail et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 124-127, issn 1052-6773, 4 p.Conference Paper

Molecular Oncology and the Neoadjuvant Setting: the Perfect Blend for Treatment Personalization and Clinical Trial DesignGENERALI, Daniele; BERRUTI, Alfredo; BOTTINI, Alberto et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 67-70, issn 1052-6773, 4 p.Conference Paper

Neoadjuvant Chemotherapy: Early Response as a Guide for Further Treatment: Clinical, Radiological, and BiologicalUNTCH, Michael; VON MINCKWITZ, Gunter.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 138-141, issn 1052-6773, 4 p.Conference Paper

New Omics Information for Clinical Trial Utility in the Primary SettingDAMIA, Giovanna; BROGGINI, Massimo; MARSONI, Silvia et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 128-133, issn 1052-6773, 6 p.Conference Paper

Predictive Immunohistochemical Biomarkers in the Context of Neoadjuvant Therapy for Breast CancerGENERALI, Daniele; SYMMANS, William F; BERRUTI, Alfredo et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 99-102, issn 1052-6773, 4 p.Conference Paper

Tissue and Soluble Biomarkers in Breast Cancer and Their Applications: Ready to Use?DANOVA, Marco; DELFANTI, Sara; MANZONI, Mariangela et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 75-78, issn 1052-6773, 4 p.Conference Paper